治疗本齐米达衍生物后的脑病变:系统性审查
Saskia Dede Davi1,2, Tamara Nordmann1,2, Lillian Rene Endamne1
1Center for Tropical Medicine, Bernhard-Nocht Institute for Tropical Medicine & I. Dept. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Open forum infectious diseases
|December 11, 2025
概括
用于病的西米达药物可能会导致高微载荷的患者严重脑胀 (脑病变). 这次系统性审查发现了六起病例,包括两起死亡,这引发了对这些治疗方法的安全担忧.
科学领域:
- 被忽视的热带疾病被忽视的热带疾病
- 寄生虫学的寄生虫学
- 药物监督 药物监督 药物监督
背景情况:
- 病是一种在西非和中非普遍存在的 filarial 疾病.
- 班齐米达 (阿尔本达,梅本达) 是治疗病的替代疗法,被认为对超微患者是安全的.
- 新出现的证据表明,本齐米达可能会触发Loa loa相关的脑病变.
研究的目的:
- 系统地审查和分析所有可用的证据,对西米达相关的脑病变在病患者.
- 在病管理的背景下,评估本齐米达治疗的安全性.
主要方法:
- 在PubMed,谷歌学者和WHO-VigiBase®中进行系统的文献搜索.
- 包括会议摘要和专家咨询.
- 分析了与西米达使用相关的脑病变的确诊病例.
主要成果:
- 鉴定出六个可能发生的与本齐米达相关的脑病变病例.
- 其中两个确定的病例导致死亡.
- 病例发生在使用本齐米达治疗的微细菌性病患者中.
结论:
- 这些确诊病例引发了对西米达在病中的使用的重大安全担忧,特别是在超微细的个体中.
- 在这个人群中,人们对本齐米达的安全感受到挑战.
- 迫切需要对胺相关脑病变的机制进行研究,并开发更安全的替代品.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Potassium Channel Activators
603
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
603
Antiepileptic Drugs: Glutamate Antagonists
857
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
857
Mania and Antimanic Drugs: Overview
526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K


